Abstract
Objective: Traditional Chinese medicine Shengxuebao Mixture (SXBM) has been approved for treating iron deficiency anemia (IDA) in China. This study aimed to collect evidence and quantify the effect of SXBM on IDA. Methods: Seven online databases were surveyed up to July 13, 2021. Randomized controlled trials in which SXBM was combined with conventional therapies to treat IDA and compared with placebo or conventional therapies were included in the study. The red blood cell (RBC) count, hemoglobin (Hb) level, serum ferritin (SF) level, and adverse events rate (AER) were evaluated. Results: A total of 1,108 patients from 8 trials were recruited. SXBM plus conventional therapy increased the Hb level (mean difference [MD] = 13.04, 95% confidence interval [CI] 8.37–17.7, p < 0.00001), RBC count (MD = 0.41, 95% CI 0.19–0.62, p = 0.002), SF level (MD = 6.25, 95% CI 2.88–9.62, p = 0.0003), and AER (risk ratio = 0.56, 95% CI 0.36–0.86; p = 0.008). Conclusions: SXBM combined with conventional treatment seemed to be beneficial for patients with IDA. However, the harmlessness of SXBM was not confirmed due to insufficient trials and low methodological quality. Follow-up clinical studies should be cautiously designed, and more research is needed.
References
1.
Camaschella
C
. Iron-deficiency anemia
. N Engl J Med
. 2015
;372
(19
):1832
–43
. .2.
Hempel
EV
, Bollard
ER
. The evidence-based evaluation of iron deficiency anemia
. Med Clin North Am
. 2016
;100
(5
):1065
–75
. .3.
Yang
C
, Zhou
DB
. Iron deficiency anemia and the development of iron supplements
. Clin Med J
. 2021
;19
(8
):18
–22
.4.
Liberati
A
, Altman
DG
, Tetzlaff
J
, Mulrow
C
, Gotzsche
PC
, Ioannidis
JPA
, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
. BMJ
. 2009
;339
:b2700
.5.
Higgins
JPT
, Green
S
, editors. Cochrane handbook for systematic reviews of interventions. Version 5.1.0
. The Cochrane Collaboration
; 2011
[updated 2011 Mar]. Available from: www.cochrane-handbook.org.6.
Chen
L
, Nie
A
, Zeng
C
. Effect of shengxuebao mixture on symptoms of patients with iron deficiency anemia of pregnancy
. Chin J Integr Med
. 2021
;25
(1
):121
–2
.7.
Guo
Y
, Chen
S
. Therapeutic value of Shengxuebao mixture in the treatment of gynecological perioperative iron-deficiency anemia
. J Pract Gynecol Endocrinol
. 2019
;6
(4
):74
–5
.8.
Huang
J
. Clinical observation on the treatment of iron deficiency anemia with shengxuebao mixture and polysaccharide iron complex
. J Clin Med
. 2018
;5
(92
):25
–6
.9.
Ke
G
, Zhang
H
, Tang
L
. Clinical study of Shengxuebao mixture combined with iron dextran dispersible tablets in the treatment of iron-deficiency anemia in pregnant women
. Heilongjiang Med J
. 2020
;44
(5
):629
–30
.10.
Pan
Q
, Li
W
, Chen
X
, Hu
J
, Liao
J
, Liu
Y
. Effect of shengxuebao mixture on iron deficiency anemia
. Med Innovat China
. 2019
;16
(34
):165
–8
.11.
Wang
Q
, Liang
J
, Wang
M
, Zhang
W
. Effect of Shenxuebao mixture for adjuvant treating pregnant women with iron deficiency anemia and its influence on their levels of mean red blood cell volume and serum ferritin and pregnancy outcomes
. Chin J Fam Plann
. 2020
;28
(7
):1053
–5
.12.
Wen
W
, Shi
L
. Randomized parallel controlled study of shengxuebao mixture in the treatment of female iron deficiency anemia
. J Pract Trad Chinese Inter Med
. 2018
;32
(11
):10
–12
.13.
Zhu
S
. Efficacy evaluation of Shengxuebao Mistura combined with ferrous sulfate tablets on the treatment of iron deficiency anemia
. Proc Clin Med
. 2019
;28
(5
):325
–8
.14.
Tolkien
Z
, Stecher
L
, Mander
AP
, Pereira
DI
, Powell
JJ
. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis
. PLoS One
. 2015
;10
(2
):e0117383
.15.
Chung
YJ
, Luo
A
, Park
KC
, Loonat
AA
, Lakhal-Littleton
S
, Robbins
PA
, Iron-deficiency anemia reduces cardiac contraction by downregulating RyR2 channels and suppressing SERCA pump activity
. JCI Insight
. 2019
;4
(7
):e125618
. .16.
Guralnik
JM
, Eisenstaedt
RS
, Ferrucci
L
, Klein
HG
, Woodman
RC
. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia
. Blood
. 2004
;104
(8
):2263
–8
.17.
Ding
L
, Xu
L
, Jin
Y
, Wei
Y
, Pan
Y
, Sattar
S
, Efficacy of SXN in the treatment of iron deficiency anemia: a phase iv clinical trial
. Evid Based Comp Alternat Med
. 2019
;2019
:8796234
.18.
Dou
L
, Gong
X
, Wu
Q
, Mou
F
. Therapeutic effects of Sheng Xue Fang in a cyclophosphamide-induced anaemia mouse model
. Pharm Biol
. 2021
;59
(1
):789
–98
. .19.
Zhu
N
, Wu
D
, Ye
B
. The progress of traditional Chinese medicine in the treatment of aplastic anemia
. J Transl Int Med
. 2018
;6
(4
):159
–64
. .20.
Huang
GC
, Chen
SY
, Tsai
PW
, Ganzon
JG
, Lee
CJ
, Shiah
HS
, Effects of Dang-Gui-Bu-Xue-Tang, an herbal decoction, on iron uptake in iron-deficient anemia
. Drug Des Devel Ther
. 2016
;10
:949
–57
. .21.
Ye
XW
, Deng
YL
, Xia
LT
, Ren
HM
, Zhang
JL
. Uncovering the mechanism of the effects of Paeoniae Radix Alba on iron-deficiency anaemia through a network pharmacology-based strategy
. BMC Complement Med Ther
. 2020
;20
(1
):130
. .22.
Zhou
ZM
, Pan
JY
, Gong
XC
, Qu
HB
, Liu
HN
, Zhang
T
, [Quantitative analysis method of Shengxuebao mixture by HPLC-UV-MS based on quality by design concept]
. Zhongguo Zhong Yao Za Zhi
. 2018
;43
(21
):4248
–54
. .23.
Pan
JY
, Zhou
ZM
, Qu
HB
, Liu
HN
, Liu
SX
, Su
YJ
, [Study on rapid quality analysis method of Shengxuebao mixture]
. Zhongguo Zhong Yao Za Zhi
. 2020
;45
(9
):2115
–21
. .24.
Zhu
Y
, Wang
L
, Yang
Z
, Wang
J
, Li
W
, Zhou
J
, Hematopoietic effects of paeoniflorin and albiflorin on radiotherapy-induced myelosuppression mice
. Evid Based Complement Alternat Med
. 2016
;2016
:5789381
. .© 2022 S. Karger AG, Basel
2022
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
